BioAge Labs, Inc. Reports Promising Preclinical Results for APJ Agonist in Enhancing Glycemic Control and Cardioprotection in Diabetic Obesity and Heart Failure
22/6 00:10
BioAge Labs announced promising preclinical results for apelin receptor agonists, showing enhanced glycemic control and cardioprotective effects in obesity and heart failure....